Grant number: 107011 | Funding period: 2022 - 2026
Active
L Earnest, DF Ruiz, MA Edeling, JC Montoya, AHY Yap, CY Wong, LE Holz, S Gras, S Collett, JP Cooney, KC Davidson, SL Grimley, DFJ Purcell, J Roberts, J Mumford, CW Tan, LF Wang, DI Godfrey, M Frieman, D Hans
2026-12-01
Whilst COVID vaccines proved to be effective in preventing severe COVID disease, they failed to control the emergence of variant v..
TP Cao, GR Liao, TY Cheng, Y Chen, L Ciacchi, TS Fulford, R Farquhar, J Kollmorgen, JA Mayfield, AP Uldrich, EZQ Ng, GS Ogg, DI Godfrey, NA Gherardin, YL Chen, DB Moody, A Shahine, J Rossjohn
For the MHC, MR1 and CD1 systems, antigen recognition involves contact of the membrane distal surfaces of both the αβ T cell recep..
TS Fulford, HF Koay, R Grumont, DN Johnson, S Scheer, HJ Nel, R Thomas, JYW Mak, DP Fairlie, CE Teh, DHD Gray, VL Bryant, C Zaph, LA O'Reilly, S Gerondakis, DI Godfrey
2026-04-01
Mucosal-associated invariant T (MAIT) cells are characterized by rapid responses to nonpeptide antigens via invariant T-cell recep..
MH Shakir Hussain, Samuel J Redmond, Wael Awad, Calvin Xu, Caroline Soliman, Lisa Ciacchi, Alexis P Gonzalez, Jeffrey YW Mak, David P Fairlie, James McCluskey, Adam P Uldrich, Jamie Rossjohn, Dale I Godfrey, Hui-Fern Koay, Nicholas A Gherardin
2026-03-25
UNLABELLED: T cell receptor mimic (TCRm) antibodies and nanobodies that specifically bind peptide-HLA complexes have great therape..
L Rashleigh, H Venugopal, MT Rice, SD Gunasinghe, CL Sok, NA Gherardin, CF Almeida, I Van Rhijn, DB Moody, DI Godfrey, J Rossjohn, BS Gully
2025-10-02
The antigen recognition principles of B cells and αβ T cells have been well described compared to those of the γδ T cell. By way o..
A Dodla, M Giergiel, A Mclean, K Kochan, L Earnest, MA Edeling, JL McAuley, DI Godfrey, DFJ Purcell, AHY Yap, JC Montoya, JA Roberts, S Collett, S Shukla, S Saxena, J Torresi, BR Wood
2025-08-19
Virus-like particles (VLPs) are recombinant, noninfectious, self-assembled structures that are made up of the viral structural pro..
W Awad, NA Gherardin, L Ciacchi, AN Keller, L Liu, DP Fairlie, J McCluskey, DI Godfrey, J Rossjohn
2025-08-01
Mucosal-associated invariant T (MAIT) cells express a TRAV1-2<sup>+</sup> T-cell receptor (TCR) that recognizes microbial vitamin ..
AT Hsu, RJJ O'Donoghue, E Tsantikos, TA Gottschalk, JG Borger, NA Gherardin, C Xu, HF Koay, DI Godfrey, M Ernst, GP Anderson, ML Hibbs
2025-05-01
Background: Chronic obstructive pulmonary disease (COPD) is a heterogeneous inflammatory lung disease leading to progressive, dest..
Hareth A Al-Wassiti, Stewart A Fabb, Samantha L Grimley, Ruby Kochappan, Joan K Ho, Chinn Yi Wong, Chee Wah Tan, Thomas J Payne, Asuka Takanashi, Chee Leng Lee, Rekha Shandre Mugan, Horatio Sicilia, Serena LY Teo, Julie McAuley, Paula Ellenberg, James P Cooney, Kathryn C Davidson, Richard Bowen, Marc Pellegrini, Steven Rockman
2024-12-12
We investigated mRNA vaccines encoding a membrane-anchored receptor-binding domain (RBD), each a fusion of a variant RBD, the tran..
C Xu, A Obers, M Qin, A Brandli, J Wong, X Huang, A Clatch, A Fayed, G Starkey, R D’costa, CL Gordon, JYW Mak, DP Fairlie, L Beattie, LK Mackay, DI Godfrey, HF Koay
2024-12-02
Unconventional T cells, including mucosal-associated invariant T (MAIT), natural killer T (NKT), and gamma-delta T (γδT) cells, co..
CF Almeida, BS Gully, CM Jones, L Kedzierski, SD Gunasinghe, MT Rice, R Berry, NA Gherardin, TT Nguyen, YF Mok, JF Reijneveld, DB Moody, I Van Rhijn, NL La Gruta, AP Uldrich, J Rossjohn, DI Godfrey
2024-12-01
αβ T cell receptors (αβTCRs) co-recognise antigens when bound to Major Histocompatibility Complex (MHC) or MHC class I-like molecu..
EC Larson, AL Ellis, MA Rodgers, AK Gubernat, JL Gleim, RV Moriarty, AJ Balgeman, YT de Menezes, CL Ameel, DJ Fillmore, SM Pergalske, JA Juno, P Maiello, HB Chishti, PL Lin, DI Godfrey, SJ Kent, DG Pellicci, LC Ndhlovu, SL O'Connor
Children living with HIV have a higher risk of developing tuberculosis (TB), a disease caused by the bacterium Mycobacterium tuber..
C Samer, HEG McWilliam, BP McSharry, JG Burchfield, RJ Stanton, J Rossjohn, JA Villadangos, A Abendroth, B Slobedman
2024-10-01
Presentation of metabolites by the major histocompatibility complex class I–related protein 1 (MR1) molecule to mucosal-associated..
Tan-Yun Cheng, T Praveena, Srinath Govindarajan, Catarina F Almeida, Daniel G Pellicci, Wellington C Arkins, Ildiko Van Rhijn, Koen Venken, Dirk Elewaut, Dale I Godfrey, Jamie Rossjohn, D Branch Moody
2024-08-01
To broadly measure the spectrum of cellular self-antigens for natural killer T cells (NKT), we developed a sensitive lipidomics sy..
TS Fulford, C Soliman, RG Castle, M Rigau, Z Ruan, O Dolezal, R Seneviratna, HG Brown, E Hanssen, A Hammet, S Li, SJ Redmond, A Chung, MA Gorman, MW Parker, O Patel, TS Peat, J Newman, A Behren, NA Gherardin
Butyrophilin (BTN) molecules are emerging as key regulators of T cell immunity; however, how they trigger cell-mediated responses ..
AH Mooney, SL Draper, OK Burn, RJ Anderson, BJ Compton, C Tang, KJ Farrand, P Di Lucia, M Ravà, V Fumagalli, L Giustini, E Bono, DI Godfrey, WR Heath, W Yuan, FV Chisari, LG Guidotti, M Iannacone, J Sidney, A Sette
2024-05-01
Background & Aims: Liver diseases resulting from chronic HBV infection are a significant cause of morbidity and mortality. Vaccine..
C Samer, HEG McWilliam, BP McSharry, T Velusamy, JG Burchfield, RJ Stanton, DC Tscharke, J Rossjohn, JA Villadangos, A Abendroth, B Slobedman
2024-02-16
The major histocompatibility complex (MHC), Class-I-related (MR1) molecule presents microbiome-synthesized metabolites to Mucosal-..
R Lameris, A Shahine, M Veth, B Westerman, DI Godfrey, DL Hulsik, P Brouwer, J Rossjohn, TD de Gruijl, HJ van der Vliet
2023-12-01
Background CD1d is a monomorphic major histocompatibility complex class I-like molecule that presents lipid antigens to distinct T..
TM Nolan, G Deliyannis, M Griffith, S Braat, LF Allen, J Audsley, AW Chung, M Ciula, NA Gherardin, ML Giles, TP Gordon, SL Grimley, L Horng, DC Jackson, JA Juno, K Kedzierska, SJ Kent, SR Lewin, M Littlejohn, HA McQuilten
Background: SARS-CoV-2 booster vaccination should ideally enhance protection against variants and minimise immune imprinting. This..
Carolien E van de Sandt, Thi HO Nguyen, Nicholas A Gherardin, Jeremy Chase Crawford, Jerome Samir, Anastasia A Minervina, Mikhail V Pogorelyy, Simone Rizzetto, Christopher Szeto, Jasveen Kaur, Nicole Ranson, Sabrina Sonda, Alice Harper, Samuel J Redmond, Hayley A McQuilten, Tejas Menon, Sneha Sant, Xiaoxiao Jia, Kate Pedrina, Theo Karapanagiotidis
2023-11-01
CD8<sup>+</sup> T cells provide robust antiviral immunity, but how epitope-specific T cells evolve across the human lifespan is un..
G Deliyannis, NA Gherardin, CY Wong, SL Grimley, JP Cooney, SJ Redmond, P Ellenberg, KC Davidson, FL Mordant, T Smith, M Gillard, E Lopez, J McAuley, CW Tan, JJ Wang, W Zeng, M Littlejohn, R Zhou, J Fuk-Woo Chan, ZW Chen
2023-06-01
Background: The SARS-CoV-2 global pandemic has fuelled the generation of vaccines at an unprecedented pace and scale. However, man..
G Cameron, T Nguyen, M Ciula, SJ Williams, DI Godfrey
2023-05-27
Natural Killer T (NKT) cells are a lipid-antigen reactive T cell subset that is restricted to the antigen presenting molecule CD1d..
L Tribolet, AM Brice, TS Fulford, DS Layton, DI Godfrey, AGD Bean, CR Stewart
2023-05-01
Inflammation and lipid regulator with UBA-like and NBR1-like domains (ILRUN) is a protein-encoding gene associated with innate imm..
CL Ashley, BP McSharry, HEG McWilliam, RJ Stanton, CA Fielding, RA Mathias, DP Fairlie, J McCluskey, JA Villadangos, J Rossjohn, A Abendroth, B Slobedman
2023-02-10
Introduction: The antigen presentation molecule MHC class I related protein-1 (MR1) is best characterized by its ability to presen..
S Collett, L Earnest, J Carrera Montoya, MA Edeling, A Yap, CY Wong, D Christiansen, J Roberts, J Mumford, V Lecouturier, V Pavot, S Marco, JK Loi, C Simmons, SA Gulab, JM Mackenzie, A Elbourne, PA Ramsland, G Cameron, D Hans
2023-01-01
The development of virus-like particle (VLP) based vaccines for human papillomavirus, hepatitis B and hepatitis E viruses represen..
P Pymm, SJ Redmond, O Dolezal, F Mordant, E Lopez, JP Cooney, KC Davidson, ER Haycroft, CW Tan, R Seneviratna, SL Grimley, DFJ Purcell, SJ Kent, AK Wheatley, LF Wang, A Leis, A Glukhova, M Pellegrini, AW Chung, K Subbarao
2022-11-18
The development of therapeutics to prevent or treat COVID-19 remains an area of intense focus. Protein biologics, including monocl..
BD Wines, L Kurtovic, HM Trist, S Esparon, E Lopez, K Chappin, LJ Chan, FL Mordant, WS Lee, NA Gherardin, SK Patel, GE Hartley, P Pymm, JP Cooney, JG Beeson, DI Godfrey, LM Burrell, MC van Zelm, AK Wheatley, AW Chung
2022-07-28
Joining a function-enhanced Fc-portion of human IgG to the SARS-CoV-2 entry receptor ACE2 produces an antiviral decoy with strain ..
G Cameron, JMH Cheng, DI Godfrey, MSM Timmer, BL Stocker, EM Dangerfield
2022-06-22
Isoglobotrihexosylceramide (iGb3) is a known NKT cell agonist, however the specific interactions required to trigger NKT cell TCR ..
H Andrlová, O Miltiadous, AI Kousa, A Dai, S DeWolf, S Violante, HY Park, S Janaki-Raman, R Gardner, S El Daker, J Slingerland, P Giardina, A Clurman, ALC Gomes, C Nguyen, MB Da Silva, GK Armijo, N Lee, R Zappasodi, R Chaligne
2022-05-25
Microbial diversity is associated with improved outcomes in recipients of allogeneic hematopoietic cell transplantation (allo-HCT)..
CF Almeida, DFJ Purcell, DI Godfrey, JL McAuley
2022-04-01
The COVID-19 pandemic caused by SARS-CoV-2 is having devastating effects on a global scale. Since common household disinfectants a..
HF Koay, NA Gherardin, THO Nguyen, W Zhang, JR Habel, R Seneviratna, F James, NE Holmes, OC Smibert, CL Gordon, JA Trubiano, K Kedzierska, DI Godfrey
2022-02-08